AzTrials
AzTrials

Chronic Low Back PainNCT06706479

The Effects of High-definition Transcranial Direct Current Stimulation on Balance Control in Older Adults With Chronic Low Back Pain

A study testing high-definition transcranial direct current stimulation in people with Chronic Low Back Pain, run by The Hong Kong Polytechnic University at 1 site in China.

Enrolling by invitation

Enrolling by invitation. The study team selects and invites participants, usually from an existing group of patients.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to investigate the effects and mechanisms of high-definition transcranial direct current stimulation over left dorsolateral prefrontal cortex on chronic low back pain and balance in older adults. Read more about this study

Who is it for?
Ages 60 to 85 years
Conditions the study is for
Chronic Low Back Pain
What is being tested?
high-definition transcranial direct current stimulation
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
1 siteChina
Study dates
10 Dec 2024to 31 Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Aged 60-85 years;
  • With non-specific chronic low back pain that has no definitive diagnosis but lasted for at least 3 months, typically occurs in the area between the lower rib margins and the buttock creases;
  • With an average pain intensity over the last week to be ≥ 3 on an 11-point numerical rating scale (NRS) anchored with "no pain" at zero and "worst pain imaginable" at 10;
  • Have normal cognitive function (Hong Kong Montreal Cognitive Assessment ≥ 22);
  • Who agree to sign an informed consent form.

Who cannot join

  • Inability to ambulate without assistance from another person or tools (e.g., canes or walkers);
  • Having specific causes of low back pain (e.g., spinal stenosis, lumbar disc herniation, spondylolisthesis, recent vertebral fracture, spinal infection);
  • Having other acute or overt musculoskeletal conditions in other parts of the body (e.g., fractures, severe pain, multiple joint pain (e.g., knee pain));
  • History of lumbar or lower extremity surgery;
  • Receiving LBP treatment within the past one month or at present;
  • Have never received non-invasive brain stimulation (e.g., transcranial direct current stimulation, repetitive transcranial magnetic stimulation, and transcranial alternating current stimulation) before.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site
  • The Hong Kong Polytechnic University

    Hong Kong, Hong Kong, 999077

Other trials in China

About this study

Official title: The Effects of High-definition Transcranial Direct Current Stimulation on Balance Control in Older Adults With Chronic Low Back Pain: a Randomized Controlled Trial

The goal of this clinical trial is to investigate the effects and mechanisms of high-definition transcranial direct current stimulation over left dorsolateral prefrontal cortex on chronic low back pain and balance in older adults. The main questions it aims to answer are:

Primary hypothesis 1: Active stimulation would have greater improvement in pain and balance, reduced left dorsolateral prefrontal cortex activation than sham stimulation.

Read more

Primary hypothesis 2: Active stimulation would have enhanced functional connectivity than sham stimulation.

Primary hypothesis 3: The balance improvement would be related to reduced pain, decreased left dorsolateral prefrontal cortex activation, enhanced functional connectivity, attention, and/or executive function.

Participants will be randomly received a single-session of high-definition transcranial direct current stimulation (active or sham stimulation). Before and immediately after the intervention, balance (semi-tandem stance and timed up-and-go test (TUG)) and cognitive (attention and executive function) tests will be assessed.

Being tested
high-definition transcranial direct current stimulation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • high-definition transcranial direct current stimulationDevice

    High-definition transcranial direct current stimulation is a novel non-invasive brain stimulation technique based on the principle that when weak intensity electric currents are targeted on specific areas of the scalp, they cause underlying cortical stimulation. The anode increases cortical excitability, while cathode decreases cortical excitability.

Study groups in NCT06706479
Study groupRoleWhat they receive
Active stimulationExperimentalFor the active stimulation, the current will be ramped up from 0 to 2 mA over the initial 30-s period and then maintain the current of 2 mA for 20 minutes, following by a 30-s ramp-down period.
Receives: Device: high-definition transcranial direct current stimulation
Sham stimulationExperimentalThe participants will receive the same intervention procedures, but the intervention will have no therapeutic effect. Specifically, for the sham stimulation, participants will only experience 30-s ramp-up and 30-s ramp-down periods at both the commencement and end of the stimulation.
Receives: Device: high-definition transcranial direct current stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Current back-pain intensity

    The current back-pain intensity will be assessed with the 11-point numerical rating scale anchored with "no pain" at zero and "worst pain imaginable" at 10.

    Measured: Before and immediately after the intervention.

Secondary outcomes (8)
  1. Resting-state blood oxygen concentration

    Resting-state blood oxygen concentration (indicated by Oxyhemoglobin concentration (μmol)) will be measured using the portable fNIRS imaging system (NIRSport 2, NIRx Medical Technologies LLC, Glen Head, NY, USA). We will instruct participants to sit still and comfortably with their eyes open, lean against the back rest, and look at a fixation cross one meter in front of them for 5 minutes.

    Measured: Before and immediately after the intervention.

  2. Arithmetic performance

    Participants will be required to perform the cognitive task in the seated postition (3 x 30s). The cognitive task is serial subtraction from a random three-digit number (200-999) by 7s audibly. The number of correct and incorrect answers will be recorded.

    Measured: Before and immediately after the intervention.

  3. Postural sway

    Postural sway will be assessed by APDM® Mobility Lab (APDM, Inc., Portland, OR, USA) in the following tests in a random order: (1) semi-tandem stance on firm surfaces without cognitive task (3 x 30s), (2) semi-tandem stance on firm surfaces with cognitive task (3 x 30s), (3) semi-tandem stance on foam surfaces without cognitive task (3 x 30s), (4) semi-tandem stance on foam surfaces with cognitive task (3 x 30s). The cognitive task is serial subtraction from a random three-digit number (200-999) by 7s audibly. No instructions are given regarding task prioritization. During the standing tests, cortical activation will be measured using the NIRSport 2 system with its control box placed in a backpack worn by participants.

    Measured: Before and immediately after the intervention.

  4. Timed up-and-go test (TUG)

    TUG will be performed in random order in the following tests: (1) TUG without a cognitive task (3 trials) and (2) TUG with a cognitive task (3 trials). The cognitive task involves serial subtraction from a random three-digit number (ranging from 200 to 999) by subtracting 7s audibly. No specific instructions are provided regarding task prioritization. The time (in seconds) taken to complete the TUG, along with the number of correct and incorrect answers, will be recorded for statistical analysis.

    Measured: Before and immediately after the intervention.

  5. Attention

    Attention will be assessed using the Trail Making Test - A (TMT-A). TMT-A involves connecting a series of 25 square and circle encircled numbers in ascending order, without lifting the pen from the paper. Errors will be corrected immediately and re-establish the sequence. The time (in seconds) to complete the TMT-A will be recorded for statistical analysis.

    Measured: Before and immediately after the intervention.

  6. Executive function

    Executive function will be assessed using TMT-A and the Trail Making Test - B (TMT-B). TMT-A involves connecting a series of 25 square and circle encircled numbers in ascending order, without lifting the pen from the paper. In TMT-B, the numbers from 1 to 25 are twice presented in square and circle shapes ("1" is only presented once). Participants are instructed to connect the numbers in ascending order, alternating between the squares and circles. Errors will be corrected immediately and re-establish the sequence. The time to complete the TMT-A and TMT-B will be recorded. Executive function will be indicated by the difference in TMT-A and TMT-B (TMT-B minus TMT-A in seconds).

    Measured: Before and immediately after the intervention.

  7. Side or adverse effects

    Any side or adverse effects (e.g., itching, tingling and burning sensations under electrodes) related to the interventions will be monitored in all participants.

    Measured: During and 1 hour after the intervention.

  8. Blinding efficacy

    A blinding efficacy questionnaire will be completed after intervention. If the participant believes that they receive active or sham stimulation, they will be asked to state their confidence in this belief on a scale of 1 (not confident) to 3 (very confident).

    Measured: Immediately after the intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Nov 2024
  2. Study start10 Dec 2024
  3. Primary completion1 Dec 2025 (estimated)
  4. Study completion31 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06706479
Sponsor's protocol ID
HSEARS20240416001
Status last verified
Apr 2025
First submitted
26 Aug 2024
Last updated
18 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing high-definition transcranial direct current stimulation in people with Chronic Low Back Pain, run by The Hong Kong Polytechnic University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: enrolling by invitation, as of the sponsor's last update on 18 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Current back-pain intensity (time frame: Before and immediately after the intervention.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Apr 2025; AzTrials last refreshed its copy on 6 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in